ArticleIranian journal of basic medical sciences2026
Inhibition of the PKC-TRPV1-SP axis by propolis ameliorates chronic inflammatory pain in mice.
Article in Iranian journal of basic medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Chronic inflammatory pain significantly affects patient quality of life; however, existing treatment methods have limitations. Propolis is rich in various bioactive ingredients, such as flavonoids and phenolic acids. This study aimed to explore the effects and action mechanisms of propolis against chronic inflammatory pain. Materials and Methods: A mouse model of chronic inflammatory pain was established using Complete Freund's adjuvant, with the mice divided into normal control, model, and propolis-treated groups. Body weight, pain score, foot volume, thermal pain threshold, mechanical pain threshold, and pathological changes in the toe tissue were recorded before injection (day 0) and on days 1, 7, 14, 21, and 28 after injection.After the experiment, changes in inflammatory factors (TNF-α, IL-4, IL-6, and IL-10) were detected, and the expression and distribution of proteins associated with the PKC-TRPV1-SP signalling axis in the toe, spinal cord, and hippocampus were detected by Western blot and immunofluorescence. Results: Propolis treatment significantly inhibited foot swelling, alleviated tissue inflammatory lesions, relieved pain, and increased heat and mechanical pain thresholds in mice. In addition, propolis inhibited the secretion of pro-inflammatory cytokines TNF-α, IL-4, and IL-6, promoted the secretion of the anti-inflammatory cytokine IL-10, and inhibited the expression of proteins related to the PKC-TRPV1-SP signalling axis. Conclusion: This study demonstrated that propolis exerts anti-inflammatory and analgesic effects by regulating the PKC-TRPV1-SP signalling axis. The findings offer new perspectives for the clinical treatment of chronic inflammatory pain and provide a reference for the development of new medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.